Jia Shen Tablet vs Shenfu injection

Same mechanism, same race: design-graded trial evidence for both assets, with the grading rationale shown. Grades describe the quality of the evidence, never the merits of either security.

Heart Failure

Shared mechanism: Multi-target (ginsenoside) · full Heart Failure pipeline

Jia Shen Tablet

Developed by Tasly Pharmaceutical Group

Phase 2 in Heart FailureBotanical (TCM)
Weak signal

NCT06348498 · Phase 1 · status unknown

This is a small, single-arm, open-label study of 18 people with chronic heart failure, designed to characterize the drug's pharmacokinetics rather than to test whether it works against a comparator, and no results have been posted.

Next expected readout: December 2026 · NCT06669169 (registry estimate)

No aligned efficacy figure on record for this race.

Shenfu injection · Shenfu Zhusheye

Marketed by China Resources Sanjiu Medical & Pharmaceutical

Botanical (TCM injection)
not yet graded

No graded featured trial for this indication yet; the grade above reflects that absence, not a judgment.

No aligned efficacy figure on record for this race.

Results for Heart Failure

Values come from each drug's own ClinicalTrials.gov study. They are from separate trials and patient populations, not a head-to-head comparison. Each result identifies its source trial, phase, arm and timepoint; limitations that apply to a whole cell are marked with a letter and listed once beneath the table. The comparison is deepest for later-stage drugs (phase 3 or approved), which usually have posted results to draw on; early-stage drugs often have none yet.

Key endpointJia Shen TabletShenfu injection
CV death or HF hospitalisation—Not reported—Not reported
HF hospitalisation—Not reported—Not reported
CV death—Not reported—Not reported
KCCQ clinical summary, change—Not reported—Not reported

CV death or HF hospitalisation

Jia Shen Tablet
—Not reported
Shenfu injection
—Not reported

HF hospitalisation

Jia Shen Tablet
—Not reported
Shenfu injection
—Not reported

CV death

Jia Shen Tablet
—Not reported
Shenfu injection
—Not reported

KCCQ clinical summary, change

Jia Shen Tablet
—Not reported
Shenfu injection
—Not reported
  1. Each cell is from that drug's own trial. Trials differ in population, design and timepoint; this is not a head-to-head comparison.
  2. An empty cell names why: Not posted (a completed Phase 3 here has no posted results yet), Trial running, Pending review (we hold the result and are checking it) or Not reported.

Jia Shen Tablet: no structured comparison results are available for Heart Failure.

Shenfu injection: no structured comparison results are available for Heart Failure.

The full competitive landscape for each asset (every same-race competitor with aligned evidence, sortable) is on the asset pages: Jia Shen Tablet's landscape · Shenfu injection's landscape